Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer

Published:2021-01-01 Issue:1 Volume:7 Page:61
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Mariotti Veronica¹,Han Hyo¹,Ismail-Khan Roohi¹,Tang Shou-Ching²,Dillon Patrick³,Montero Alberto J.⁴,Poklepovic Andrew⁵,Melin Susan⁶,Ibrahim Nuhad K.⁷,Kennedy Eugene⁸,Vahanian Nicholas⁸,Link Charles⁸,Tennant Lucy⁸,Schuster Shelly⁸,Smith Chris⁸,Danciu Oana⁹,Gilman Paul¹⁰,Soliman Hatem¹

Affiliation:

1. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

2. University of Mississippi Cancer Center and Research Institute, Jackson

3. University of Virginia, Charlottesville

4. Cleveland Clinic, Cleveland, Ohio

5. Virginia Commonwealth University, Richmond

6. Wake Forest University, Winston-Salem, North Carolina

7. MD Anderson Cancer Center, Houston, Texas

8. NewLink Genetics Corporation, Ames, Iowa

9. University of Illinois at Chicago

10. Lankenau Institute for Medical Research, Wynnewood, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2772792/jamaoncology_mariotti_2020_oi_200081_1609897930.8728.pdf

Reference25 articles.

1. Prevention of allogeneic fetal rejection by tryptophan catabolism.;Munn;Science,1998

2. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.;Frumento;J Exp Med,2002

3. Modulation of tryptophan catabolism by regulatory T cells.;Fallarino;Nat Immunol,2003

4. Indoleamine 2,3-dioxygenase (IDO): only an enzyme or a checkpoint controller?;Bilir;J Oncological Sci.,2017

5. IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: a novel IDO effector pathway targeted by D-1-methyl-tryptophan.;Metz;Oncoimmunology,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving Immune Activation by Suppressing the IDO1 Checkpoint with Sono-Targeted Biobromination for Antitumor Combination Immunotherapy;Journal of the American Chemical Society;2024-08-21

2. Qingfei mixture mitigates immunosuppression of tumor microenvironment in non-small cell lung cancer by blocking stat1/Ido1-mediated tryptophan-kynurenine pathway;Heliyon;2024-06

3. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15

4. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities;Biomarker Research;2024-01-07

5. Combination Chemotherapy Optimization with Discrete Dosing;INFORMS Journal on Computing;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3